Literature DB >> 6457999

Effects of dexamethasone on fibre subtypes in rat muscle.

I Livingstone, M A Johnson, F L Mastaglia.   

Abstract

The extent to which dexamethasone treatment produced atrophy of fast-twitch (EDL) and slow-twitch (SOL) muscles in rat was investigated. The mean weight of steroid-treated EDL muscles was decreased as compared to normal, whereas SOL muscles from normal and dexamethasone-treated animals showed no significant difference. Muscle fibre diameters also showed comparatively minor changes in SOL, which consists of Type 1 (slow oxidative) and Type 2A (fast oxidative/glycolytic) fibres. Rat EDL contains, in addition to Type 1 and Type 2A fibres, two sub-populations of fast glycolytic fibres (Types 2B and 2B'). These fibre types showed the most severe degree of atrophy both after dexamethasone treatment and after denervation. The mean ratio of the weights of denervated to innervated EDL muscles was lower in steroid-treated rats than in normal animals suggesting that the atrophy produced by steroid treatment in conjunction with denervation was more than simply additive. Analysis of the proportions of histochemical fibre types in SOL and EDL showed that dexamethasone treatment produced no major alterations in the fibre type constitution of these muscles. However, further histochemical studies showed that there was relatively severe impairment of myophosphorylase activity in Type 2B' (fast glycolytic) fibres as compared to other fibre types; conversely Type 1 fibres frequently contained increased myophosphorylase. Levels of beta-hydroxybutyrate dehydrogenase were low in both normal and steroid-treated EDL but high in SOL which also showed higher general oxidative activity. It is suggested that the particular susceptibility of fast glycolytic fibres to atrophy as a result of steroid treatment may be linked to: 1 the relatively severe reduction of myophosphorylase activity in these fibres and 2 their comparative inability to utilize alternative energy sources, especially substrates derived from free fatty acids.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6457999     DOI: 10.1111/j.1365-2990.1981.tb00240.x

Source DB:  PubMed          Journal:  Neuropathol Appl Neurobiol        ISSN: 0305-1846            Impact factor:   8.090


  8 in total

1.  Effects of perinatal high dose dexamethasone on skeletal muscle development in rats.

Authors:  J E Steiss; J C Wright; N R Cox
Journal:  Can J Vet Res       Date:  1989-01       Impact factor: 1.310

Review 2.  Adverse effects of drugs on muscle.

Authors:  F L Mastaglia
Journal:  Drugs       Date:  1982-10       Impact factor: 9.546

3.  Evaluation of laryngeal findings in users of inhaled steroids.

Authors:  Gul Ozbilen Acar; Nurten Uzun Adatepe; Asim Kaytaz; Deniz Tuna Edizer; Bilun Gemicioglu; Cengiz Yagiz; Ahmet Dirican
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-11-12       Impact factor: 2.503

4.  Effects of dexamethasone on the expression of beta(1)-, beta (2)- and beta (3)-adrenoceptor mRNAs in skeletal and left ventricle muscles in rats.

Authors:  Fuuun Kawano; Jun Tanihata; Shogo Sato; Sachiko Nomura; Akira Shiraishi; Kaoru Tachiyashiki; Kazuhiko Imaizumi
Journal:  J Physiol Sci       Date:  2009-07-08       Impact factor: 2.781

5.  The Electrical Stimulation of the Bed Nucleus of the Stria Terminalis Causes Oxidative Stress in Skeletal Muscle of Rats.

Authors:  Mateusz Jakub Karnia; Dorota Myslinska; Katarzyna Patrycja Dzik; Damian Jozef Flis; Ziemowit Maciej Ciepielewski; Magdalena Podlacha; Jan Jacek Kaczor
Journal:  Oxid Med Cell Longev       Date:  2018-05-31       Impact factor: 6.543

6.  Sirtuin 6 inhibition protects against glucocorticoid-induced skeletal muscle atrophy by regulating IGF/PI3K/AKT signaling.

Authors:  Sneha Mishra; Claudia Cosentino; Ankit Kumar Tamta; Danish Khan; Shalini Srinivasan; Venkatraman Ravi; Elena Abbotto; Bangalore Prabhashankar Arathi; Shweta Kumar; Aditi Jain; Anand S Ramaian; Shruti M Kizkekra; Raksha Rajagopal; Swathi Rao; Swati Krishna; Ninitha Asirvatham-Jeyaraj; Elizabeth R Haggerty; Dafne M Silberman; Irwin J Kurland; Ravindra P Veeranna; Tamilselvan Jayavelu; Santina Bruzzone; Raul Mostoslavsky; Nagalingam R Sundaresan
Journal:  Nat Commun       Date:  2022-09-15       Impact factor: 17.694

7.  Transcriptomic markers meet the real world: finding diagnostic signatures of corticosteroid treatment in commercial beef samples.

Authors:  Sara Pegolo; Guglielmo Gallina; Clara Montesissa; Francesca Capolongo; Serena Ferraresso; Caterina Pellizzari; Lisa Poppi; Massimo Castagnaro; Luca Bargelloni
Journal:  BMC Vet Res       Date:  2012-10-30       Impact factor: 2.741

Review 8.  Proliferative and non-proliferative lesions of the rat and mouse soft tissue, skeletal muscle and mesothelium.

Authors:  Peter Greaves; Luc Chouinard; Heinrich Ernst; Lars Mecklenburg; Ingrid M Pruimboom-Brees; Matthias Rinke; Susanne Rittinghausen; Stéphane Thibault; Jasmin Von Erichsen; Toshinori Yoshida
Journal:  J Toxicol Pathol       Date:  2013       Impact factor: 1.628

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.